Sign in

CIK 0001743881 · Large accelerated filer

BridgeBio Pharma, Inc.

Sign in to watch
Ticker
BBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(650) 391-9740
Business address
3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
Former names
BridgeBio Pharma LLC
  1. SCHEDULE 13D/A Stake Beneficial Ownership Report
  2. 144 Insider Sale of Securities
  3. 144 Insider Sale of Securities
  4. SCHEDULE 13G Stake Statement of Beneficial Ownership
  5. 4 Planned sale Chief Executive Officer sold 80,000 shares at an average $71.86 ($5,748,666)
  6. 8-K Event Other events
  7. 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
  8. 4 Planned sale Chief Executive Officer sold 80,000 shares at an average $75.54 ($6,043,168)
  9. 8-K Event Results of operations · Regulation FD disclosure · Other events
  10. 144 Insider Sale of Securities
  11. 144 Insider Sale of Securities
  12. 4 Planned sale Chief Executive Officer sold 30,011 shares at an average $74.64 ($2,239,902)
  13. 4 Shares withheld for taxes President and CFO gave up 13,826 shares (to pay taxes)
  14. 4 Shares withheld for taxes Chief Accounting Officer gave up 2,003 shares (to pay taxes)
  15. 144 Insider Sale of Securities
  16. 4 Planned sale Chief Accounting Officer sold 2,000 shares at $74.26 ($148,520)
  17. 4 Planned sale Chief Executive Officer sold 80,000 shares at an average $73.86 ($5,908,476)
  18. 4 Planned sale Chief Executive Officer sold 26,156 shares at an average $65.84 ($1,722,224)
  19. 144 Insider Sale of Securities
  20. 4 Open-market sale Director sold 95,599 shares at an average $66.11 ($6,319,662)

Page 6 of 42 · 834 filings